[Therapy for high-risk MDS].
Okamoto
T
T
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D012074:Remission Induction; D012306:Risk
D000970:Antineoplastic Agents